Skip to main content

4 Result(s)

within Enli Liu Remove this filter Infectious Diseases Remove this filter

and

  1. Article

    Author Correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape

    Ye Li, Rafet Basar, Guohui Wang, Enli Liu, Judy S. Moyes, Li Li… in Nature Medicine (2024)

    Download PDF (603 KB) View Article

  2. Article

    Open Access

    Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial

    There is a pressing need for allogeneic chimeric antigen receptor (CAR)-immune cell therapies that are safe, effective and affordable. We conducted a phase 1/2 trial of cord blood-derived natural killer (NK) c...

    David Marin, Ye Li, Rafet Basar, Hind Rafei, May Daher, **zhuang Dou… in Nature Medicine (2024)

    Download PDF (11504 KB) View Article

  3. No Access

    Article

    KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape

    Trogocytosis is an active process that transfers surface material from targeted to effector cells. Using multiple in vivo tumor models and clinical data, we report that chimeric antigen receptor (CAR) activati...

    Ye Li, Rafet Basar, Guohui Wang, Enli Liu, Judy S. Moyes, Li Li… in Nature Medicine (2022)

  4. No Access

    Article

    Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

    The promise of engineered T cells for treating cancer has been mitigated by their poor persistence when transferred to patients. Pule et al. now show that dual-specific T cells that recognize an Epstein-Barr viru...

    Martin A Pule, Barbara Savoldo, G Doug Myers, Claudia Rossig… in Nature Medicine (2008)